Matches in Wikidata for { <http://www.wikidata.org/entity/Q89243171> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q89243171 description "article scientifique publié en 2014" @default.
- Q89243171 description "artículu científicu espublizáu n'ochobre de 2014" @default.
- Q89243171 description "im Oktober 2014 veröffentlichter wissenschaftlicher Artikel" @default.
- Q89243171 description "scientific article published on 26 October 2014" @default.
- Q89243171 description "wetenschappelijk artikel" @default.
- Q89243171 description "наукова стаття, опублікована в жовтні 2014" @default.
- Q89243171 description "գիտական հոդված հրատարակված 2014 թվականի հոկտեմբերի 26-ին" @default.
- Q89243171 name "Cost-Effectiveness Model of Pertuzumab in Combination with Trastuzumab and Docetaxel Compared with Trastuzumab in Combination with Docetaxel for the 1st Line Treatment of HER2+ Metastatic Breast Cancer in Colombia" @default.
- Q89243171 name "Cost-Effectiveness Model of Pertuzumab in Combination with Trastuzumab and Docetaxel Compared with Trastuzumab in Combination with Docetaxel for the 1st Line Treatment of HER2+ Metastatic Breast Cancer in Colombia" @default.
- Q89243171 type Item @default.
- Q89243171 label "Cost-Effectiveness Model of Pertuzumab in Combination with Trastuzumab and Docetaxel Compared with Trastuzumab in Combination with Docetaxel for the 1st Line Treatment of HER2+ Metastatic Breast Cancer in Colombia" @default.
- Q89243171 label "Cost-Effectiveness Model of Pertuzumab in Combination with Trastuzumab and Docetaxel Compared with Trastuzumab in Combination with Docetaxel for the 1st Line Treatment of HER2+ Metastatic Breast Cancer in Colombia" @default.
- Q89243171 prefLabel "Cost-Effectiveness Model of Pertuzumab in Combination with Trastuzumab and Docetaxel Compared with Trastuzumab in Combination with Docetaxel for the 1st Line Treatment of HER2+ Metastatic Breast Cancer in Colombia" @default.
- Q89243171 prefLabel "Cost-Effectiveness Model of Pertuzumab in Combination with Trastuzumab and Docetaxel Compared with Trastuzumab in Combination with Docetaxel for the 1st Line Treatment of HER2+ Metastatic Breast Cancer in Colombia" @default.
- Q89243171 P1433 Q89243171-5470DF6D-32B9-45FA-AD1B-F6DD694BF4B3 @default.
- Q89243171 P1476 Q89243171-3A8E7747-EC24-4B7C-BDBD-F9F5AC9E98BA @default.
- Q89243171 P2093 Q89243171-9859AE62-693A-48DA-8240-6BA456C2BF23 @default.
- Q89243171 P304 Q89243171-F8BD94CE-FA5A-413B-8EEA-E1FE384276EE @default.
- Q89243171 P31 Q89243171-05BF1518-B664-41BB-B5ED-D979ECCFC878 @default.
- Q89243171 P356 Q89243171-D44DA5F5-A8DE-4256-9FFB-2266E9A9102D @default.
- Q89243171 P433 Q89243171-63AABFF7-2DE1-4E75-8352-51E556ADF4E0 @default.
- Q89243171 P478 Q89243171-0D5FF652-AD64-4E67-A038-831C54D712CC @default.
- Q89243171 P577 Q89243171-F1674982-15D6-495A-8863-3535B65CAD8E @default.
- Q89243171 P698 Q89243171-0CD896AE-6809-4F8D-8113-7D89B30E2F85 @default.
- Q89243171 P921 Q89243171-2E5A8D88-BB2A-4FFF-9DE4-F1A43FC8CEC4 @default.
- Q89243171 P921 Q89243171-C344F51F-2586-4A3D-A490-5E23F46A76A4 @default.
- Q89243171 P921 Q89243171-CF27B620-E29D-4299-95D9-A0F3D833BF1F @default.
- Q89243171 P921 Q89243171-D6B325D9-A43B-4BA4-9DB8-B39F1CD61F20 @default.
- Q89243171 P356 J.JVAL.2014.08.2258 @default.
- Q89243171 P698 27202242 @default.
- Q89243171 P1433 Q15766908 @default.
- Q89243171 P1476 "Cost-Effectiveness Model of Pertuzumab in Combination with Trastuzumab and Docetaxel Compared with Trastuzumab in Combination with Docetaxel for the 1st Line Treatment of HER2+ Metastatic Breast Cancer in Colombia" @default.
- Q89243171 P2093 "Ariza S A Saenz" @default.
- Q89243171 P304 "A631" @default.
- Q89243171 P31 Q13442814 @default.
- Q89243171 P356 "10.1016/J.JVAL.2014.08.2258" @default.
- Q89243171 P433 "7" @default.
- Q89243171 P478 "17" @default.
- Q89243171 P577 "2014-10-26T00:00:00Z" @default.
- Q89243171 P698 "27202242" @default.
- Q89243171 P921 Q12859063 @default.
- Q89243171 P921 Q412616 @default.
- Q89243171 P921 Q420436 @default.
- Q89243171 P921 Q739 @default.